Detecting the “Sham” in Speaker Programs
In late March 2016, Novartis Pharmaceuticals Corp. (NPC) and the U.S. Department of Justice and the State of New York…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2016
Ex-Pharma Sales Staff Arrested on Anti-Kickback Charges
It was recently announced that Jonathan Roper, a former District Manager at Insys Therapeutics, and Fernando Serrano, a…
FDA Issues Guidance on Expanded Access to Investigational Drugs
The United States Food and Drug Administration (FDA) has recently issued guidance in response to a request in the 21st…
Salix Settlement Approved
On Thursday, June 9, 2016, United States District Court Judge Denise L. Cote approved a settlement stipulation to…
Pricing Bills Are Popping Up Everywhere – Review of State Prescription Drug…
The price of prescription drugs has created much controversy in recent years. This article examines why the…
Better Patient Care Doesn’t Necessarily Equal Patient Savings
In October 2012, the Centers for Medicare and Medicaid Services launched the Comprehensive Primary Care Initiative, in…
Utah “Suggestion Sheet” of Ideas to Combat Opioid Epidemic
It's no secret that state legislatures are under intense pressure to take action to battle the opioid addiction problems…
Vermont Governor Signs Drug Price Transparency Bill
On Friday, June 3, 2016, Vermont Governor Peter Shumlin signed into law a bill that aims to require greater transparency on behalf…
Shatterproof Report on Critical Elements of Effective State Opioid…
The opioid epidemic has been a prominent talking point in many circles lately, including physician groups, Congress,…
FDA Announces Information Collection Regarding Biosimilar Suffixes
The Food and Drug Administration (FDA) has announced an information collection seeking sponsors of past and present…